Fraser Claire 4
4 · Seres Therapeutics, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Fraser Claire
Director
Transactions
- Award
Stock Option (right to buy)
2023-01-04+48,000→ 48,000 totalExercise: $5.47Exp: 2033-01-03→ Common Stock (48,000 underlying)
Footnotes (1)
- [F1]The option will vest in four equal installments on each anniversary of January 4, 2023 or in full immediately prior to the occurrence of a change in control.